Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial, viral, and fungal surface antigens are a diverse group of molecules, including proteins, polysaccharides, and lipids, located on the exterior of pathogenic microorganisms. These molecules are essential for the pathogen's life cycle, mediating critical processes such as host cell adhesion, entry, and evasion of the host immune response (Baron S, Medical Microbiology, 1996). As the most accessible components of a pathogen, they serve as the primary targets for the host's adaptive immune system and are the foundation for the design of most vaccines and therapeutic monoclonal antibodies (Janeway et al., Immunobiology, 2001). For instance, viral envelope proteins like the SARS-CoV-2 spike protein or bacterial capsular polysaccharides are targeted to prevent infection or facilitate pathogen clearance (NIH, 2023). Therapeutic intervention against these antigens often involves neutralization, where drug binding prevents the pathogen from interacting with host receptors, or opsonization, which marks the pathogen for destruction by phagocytes. However, the high degree of diversity and the potential for rapid antigenic evolution, such as antigenic drift in viruses, pose significant challenges for long-term therapeutic efficacy (Nature Reviews Microbiology, 2018).
Binding to pathogen surface components to neutralize infectivity, inhibit cell wall synthesis, or promote immune-mediated clearance via opsonization and complement activation.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial, viral, and fungal surface antigen.